FOLFIRINOX Induction Therapy for Stage 3 Pancreatic Adenocarcinoma

Radiological and Surgical Implications of Neoadjuvant Treatment With FOLFIRINOX for Locally Advanced and Borderline Resectable Pancreatic Cancer

(2015) Cristina R. Ferrone et al.   ANNALS OF SURGERY

A Single-Arm, Nonrandomized Phase II Trial of Neoadjuvant Gemcitabine and Oxaliplatin in Patients With Resectable Pancreas Adenocarcinoma

(2013) Eileen M. OʼReilly et al.   ANNALS OF SURGERY

Outcomes with FOLFIRINOX for borderline resectable and locally unresectable pancreatic cancer

(2013) Brian A. Boone et al.   JOURNAL OF SURGICAL ONCOLOGY

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

(2013) Daniel D. Von Hoff et al.   NEW ENGLAND JOURNAL OF MEDICINE

FOLFIRINOX in Locally Advanced Pancreatic Cancer: The Massachusetts General Hospital Cancer Center Experience

(2013) J. E. Faris et al.   ONCOLOGIST

A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma

(2012) Peter J Hosein et al.   BMC CANCER

Induction gemcitabine and oxaliplatin therapy followed by a twice-weekly infusion of gemcitabine and concurrent external-beam radiation for neoadjuvant treatment of locally advanced pancreatic cancer

(2012) Francesco Leone et al.   CANCER

Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators

(2012) Matthew H. G. Katz et al.   CANCER

Downstaging in Pancreatic Cancer: A Matched Analysis of Patients Resected Following Systemic Treatment of Initially Locally Unresectable Disease

(2011) K. A. Bickenbach et al.   ANNALS OF SURGICAL ONCOLOGY

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

(2011) Thierry Conroy et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Phase II Study of Gemcitabine in Combination With Radiation Therapy in Patients With Localized, Unresectable, Pancreatic Cancer

(2010) Higinia R. Cardenes et al.   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

Full-Dose Gemcitabine With Concurrent Radiation Therapy in Patients With Nonmetastatic Pancreatic Cancer: A Multicenter Phase II Trial

(2008) William Small et al.   JOURNAL OF CLINICAL ONCOLOGY